Abstract
Catechin has anti-inflammatory and antioxidative effects. Cardiotoxicity, which results from intense cardiac oxidative stress and inflammation, is the main limiting factor of the adriamycin use in the treatment of malignant tumors. Thus, the present study aimed to assess the antioxidant and anti-inflammatory effects of catechin on adriamycin-induced cardiotoxicity in rats. Forty-five rats were allocated to three groups: control group, adriamycin group and adriamycin + catechin group. We performed the following measurements: lipid peroxidation (MDA), catalase (CAT), glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities as well as, the expression of inflammatory cytokines genes namely nuclear factor kappa-B, tumor necrosis factor and inducible nitric oxide synthase. Catechin administration significantly decreased MDA level and significantly increased CAT, GSH-Px and SOD activities. Also, catechin significantly decreased the expression levels of inflammatory cytokines. Catechin provided cardioprotection on adriamycin-induced cardiotoxicity through their antioxidant and anti-inflammatory properties.
Similar content being viewed by others
References
Bast A, Kaiserová H, Hartog G, Haenen G, Vijgh W (2007) Protectors against adriamycininduced cardiotoxicity: flavonoids. Cell Biol Toxicol 23(1):39–47
Sari FR, Arozal W, Watanabe K, Harima M, Veeravedu PT, Thandavarayan RA, Suzuki K, Arumugam S, Soetikno V, Kodama M (2011) Carvedilol attenuates inflammatory-mediated cardiotoxicity in daunorubicin-induced rats. Pharmaceuticals 4:551–566
Weinstein DM, Mihm MJ, Bauer JA (2002) Cardiac peroxynitrite formation and left ventricular dysfunction following adriamycin treatment in mice. J Pharmacol Exp Ther 94:396–401
Goormaghtigh E, Huart P, Praet M, Brasseur R, Ruysschaert JM (1990) Structure of the adriamycin-cardiolipin complex role in mitochondrial toxicity. Biophys Chem 35:247–257
Lebrecht DMS, Setzer B, Ketelsen UP, Haberstroh J, Walker UA (2003) Time-dependant and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic adriamycin cardiomyopathy. Circulation 108:2423–2429
Abou El Hassan MA, Verheul HM, Jorna AS, Schalkwijk C, van Bezu J, van der Vijgh WJ, Bast A (2003) The new cardio-protector Monohydroxyethylrutoside protects against adriamycin-induced inflammatory effects in vitro. Br J Cancer 89:357–362
Hou G, Dick R, Abrams GD, Brewer GJ (2005) Tetrathiomolybdate protects against cardiac damage by adriamycin in mice. J Lab Clin Med 146:299–303
Riad A, Bien S, Westermann D, Becher PM, Loya K, Landmesser U, Kroemer HK, Schultheiss HP, Tschöpe C (2009) Pretreatment with statin attenuates the cardiotoxicity of adriamycin in mice. Cancer Res 69:695–699
Stoclet JC, Muller B, György K, Andriantsiothaina R, Kleschyov AL (1999) The inducible nitric oxide synthase in vascular and cardiac tissue. Eur J Pharmacol 375:139–155
Turpaev KT (1998) Nitric oxide in intercellular communication. Mol Biol 32:475–484
Suzuki JI, Ogawa M, Futamatsu H, Kosuge H, Sagesaka YM, Isobe M (2007) Tea catechin improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis. Eur J Heart Fail 9:152–159
Lin YL, Lin JK (1997) (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 52:465–472
Benelli R, Vene R, Bisacchi D, Garbisa S, Albini A (2002) Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem 383:101–105
Kalender S, Kalender Y, Ates A, Yel M, Olcay E, Candan S (2002) Protective role of antioxidant vitamin E and catechin on idarubicin-induced cardiotoxicity in rats. Braz J Med Biol Res 35:1379–1387
Rabelo E, De Angelis K, Bock P, Tânia Fernandes G, Cervo F, Klein AB, Clausell N, Irigoyen MC (2001) Baroreflex sensitivity and oxidative stress in adriamycin-induced heart failure. Hypertension 38:576–580
Kalender Y, Yel M, Kalender S (2005) Adriamycin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology 209:39–45
Okhawa H, Oohishi N, Yagi K (1979) Assay for Lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 95:351–358
Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325–333
Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Chemic Academic Press Inc., Verlag, New York, pp 673–685
Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 21:130–132
Liu B, Li H, Qu H, Sun B (2006) Nitric oxide synthase expressions in ADR-induced cardiomyopathy in rats. J Biochem Mol Biol 39(6):759–765
Lou H, Danelisen I, Singal PK (2004) Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure. JMCC 36:683–690
Gabr MM, Hussein AM, Sherif IO, Ali SI, Mohamed HE (2011) Renal ischemia/reperfusion injury in type II DM: possible role of proinflammatory cytokines, apoptosis, and nitric oxide. J Physiol Pathophysiol 2(1):6–17
Lefrak EA, Pitha J, Rosenheim S, GFottiebm JA (1973) A clinicopathological analysis of adriamycin cardiotoxicity. Cancer 32:302–314
O’Brien PJ, Dameron GW, Beck ML, Kang YJ, Erickson BK, Di Battista TH (1997) Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sci 47:486–495
Umlauf J, Horký M (2002) Molecular biology of adriamycin-induced cardiomyopathy. Exp Clin Cardiol 7(1):35–39
Patil L, Balaraman R (2011) Effect of green tea extract on adriamycin induced cardiovascular abnormalities: antioxidant action. Iran J Pharm Res 10(1):89–96
Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, Hofman A, Rosenblat M, Volkova N, Presser D, Attias J, Hayek T, Fuhrman B (2002) Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res 28:49–62
Takabayashi F, Harada N (1997) Effects of green tea catechin (Polyphenon 100) on cerulein-induced acute pancreatitis in rats. Pancreas 14:276–279
Lambert JD, Yang CS (2003) Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 523–524:201–208
Locher R, Emmanuele L, Suter PM, Vetter W, Barton M (2002) Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. Eur J Pharmacol 434:1–7
Li T, Singal PK (2000) Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 102:2105–2110
Heger J, Godecke A, Flogel U (2002) Cardiac-specific overexpression of inducible nitric oxide synthase dose not results in severe cardiac dysfunction. Circulation Res 90:93–99
Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, Kalyanaraman B (2002) Activation of nuclear factor-κB during adriamycin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem J 367:729–740
Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Talwar KK, Maulik SK (2003) Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression. BMC Pharmacol 3:16
Takimoto Y, Aoyama T, Tanaka K, Keyamura R, Yui Y (2002) Augmented expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats. Circulation 105:490–496
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abd El-Aziz, T.A., Mohamed, R.H., Pasha, H.F. et al. Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats. Clin Exp Med 12, 233–240 (2012). https://doi.org/10.1007/s10238-011-0165-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-011-0165-2